Hostname: page-component-74656f9884-kv2lp Total loading time: 0 Render date: 2026-11-06T12:39:01.596Z Has data issue: false hasContentIssue false

Mortality forecasting using a modified Continuous Mortality Investigation Mortality Projections Model for China I: methodology and country-level results

Published online by Cambridge University Press:  20 September 2016

Fei Huang*
Affiliation:
Research School of Finance, Actuarial Studies and Statistics, College of Business and Economics, Australian National University, Canberra, ACT 2601, Australia
Bridget Browne
Affiliation:
Research School of Finance, Actuarial Studies and Statistics, College of Business and Economics, Australian National University, Canberra, ACT 2601, Australia
*
*Correspondence to: Fei Huang, Research School of Finance, Actuarial Studies and Applied Statistics, College of Business and Economics, Australian National University, Canberra, ACT 2601, Australia. Tel: +(61) 2 612 57390. Fax: +(61) 2 612 50087. E-mail: fei.huang@anu.edu.au
Rights & Permissions [Opens in a new window]

Abstract

In this paper, we project future mortality rates for actuarial use with Chinese data using a modified Continuous Mortality Investigation (CMI) Mortality Projections Model. The model adopts a convergence structure from “initial” to “long-term” rates of mortality improvement as the process of projection. The initial rates of mortality improvement are derived using two-dimensional P-spline methodology. Given the short history of Chinese data, the long-term rates of mortality improvement are determined by borrowing information from international experience. K-means clustering with dynamic time warping distance is used to classify populations, which is novel in the actuarial mortality research field. The original CMI approach is deterministic, however, in this paper we make it stochastic using techniques outlined by Koller and described by Browne et al. Comparing our results with a pure extrapolative approach, we find that the CMI Mortality Projections Model is more suitable for long-term projections for China.

Information

Type
Papers
Copyright
© Institute and Faculty of Actuaries 2016 
Figure 0

Table 1 Data sources.

Figure 1

Figure 1 Plots of log death rates for males: census, 1% survey and 0.1% survey.

Figure 2

Figure 2 Plots of log death rates for females: census, 1% survey and 0.1% survey.

Figure 3

Figure 3 Plots of log death rates for males, 2000 and 2010.

Figure 4

Figure 4 Plots of log death rates for females, 2000 and 2010.

Figure 5

Figure 5 Comparison of period life expectancies for people aged 20 in years 2000 and 2010. CN, China; TW, Taiwan; US, United States; EW, England and Wales; JP, Japan.

Figure 6

Figure 6 Plots of the actual/crude (left-hand side of each panel) and fitted/smoothed (right-hand side of each panel) log mortality rates for (a) males and (b) females.

Figure 7

Figure 7 Plot of the log base mortality rates, 2009.

Figure 8

Figure 8 Rainbow plots of the historical smoothed rates of mortality improvement for (a) males and (b) females, 1998–2011.

Figure 9

Figure 9 Heatmaps of the historical smoothed mortality improvement rates for (a) males and (b) females, 1998–2011.

Figure 10

Figure 10 The initial rates of mortality improvement, 2009.

Figure 11

Figure 11 Long-term rates of mortality improvement based on Taiwan and the United States.

Figure 12

Table 2 Clustering analysis on κ(t).

Figure 13

Figure 12 Period of convergence.

Figure 14

Figure 13 Historical and projected mortality improvement rates for (a) males and (b) females, 1998–2049.

Figure 15

Figure 14 Historical and projected log mortality rates for (a) males and (b) females, 1997–2049.

Figure 16

Figure 15 Projected cohort life expectancy.

Figure 17

Figure 16 Projected period life expectancy.

Figure 18

Figure 17 Long-term rates of mortality improvement, Europe, 40 years.

Figure 19

Figure 18 Long-term rates of mortality improvement, Europe, 155 years.

Figure 20

Figure 19 Projected rates of mortality improvement, sensitivity analysis of long-term rates of mortality improvement (six European countries, 40 years) for (a) males and (b) females, 1998–2049.

Figure 21

Figure 20 Projected rates of mortality improvement, sensitivity analysis of long-term rates of mortality improvement (six European countries, 155 years) for (a) males and (b) females, 1998–2049.

Figure 22

Figure 21 Historical and projected mortality rates, sensitivity analysis of long-term rates of mortality improvement (six European countries, 40 years) for (a) males and (b) females, 1997–2049.

Figure 23

Figure 22 Historical and projected mortality rates, sensitivity analysis of long-term rates of mortality improvement (six European countries, 155 years) for (a) males and (b) females, 1997–2049.

Figure 24

Figure 23 Projected cohort life expectancy for (a) males and (b) females (six European countries, 40 years).

Figure 25

Figure 24 Projected cohort life expectancy for (a) males and (b) females (six European countries, 155 years).

Figure 26

Figure 25 Illustration of the operation of the convergence formula over a 40-year period, with various proportions of convergence remaining at mid-point (CMI, 2009).

Figure 27

Figure 26 Historical and projected rates of mortality improvement for males aged 50.

Figure 28

Figure 27 Cohort life expectancy for various ages with various proportions remaining at the mid-point for (a) males and (b) females.

Figure 29

Figure 28 Crude log death rates for (a) males and (b) females, 1981–2010.

Figure 30

Figure 29 Smoothed log death rates for (a) males and (b) females, 1981–2010.

Figure 31

Figure 30 Estimated mu for (a) males and (b) females.

Figure 32

Figure 31 Estimated sigma for (a) males and (b) females.

Figure 33

Figure 32 Projected log mortality rates with 95% and 99% confidence intervals for males and females, age=55.

Figure 34

Figure 33 Projected cohort life expectancy with 95% confidence intervals for (a) males and (b) females.

Figure 35

Table 3 Formulae for the mortality models: M1–M8.

Figure 36

Table 4 Model comparison – male.

Figure 37

Table 5 Model comparison – female.

Figure 38

Figure 34 Projected rates of mortality improvement for (a) males and (b) females (1998–2049), M1 (Lee–Carter model).

Figure 39

Figure 35 Projected mortality rates for (a) males and (b) females (2010–2049), M1 (Lee–Carter model).

Figure 40

Figure 36 Projected cohort life expectancy for (a) males and (b) females, comparison of Continuous Mortality Investigation (CMI) and M1 (Lee–Carter Model).

Figure 41

Figure 37 Projected rates of mortality improvement (1998–2049), males, (a) M3 and (b) M7 models.